MetS may involve many risk factors that can cause serious disorders in multiple organs. However, women with risk values involving plasma atherogenic index log (TG-to-HDL-C) experienced the highest risk of developing MetS.
The purpose of this study was to investigate whether variant (rs178 17449, G/T) in the first intron of the fat mass and obesity-associated gene (FTO) was related to different obesity parameters and blood pressure in mature women from Slovakia. A total of 419 Slovak women (241 premenopausal and 178 postmenopausal) ranging in age from 39 to 65 years were recruited from different parts of Slovakia. The subgroups were categorized based on the WHO (1996) criteria. All participants gave written informed consent for participation in this study. Anthropometric parameters were measured using standard methods. Fat mass was examined by bioimpedance and blood pressure was measured in the morning during the medical examination. Genomic DNA was extracted from blood or saliva samples by the JET-QUICK Tissue DNA spine kit. The FTO variant was determined by PCR and restriction analysis according to the methodology of Hubacek et al. (2008). The obtained data were statistically analyzed by SPSS 17.0 for Windows. The FTO genotype and allele frequencies in the entire sample and in subgroups according to their menopausal and blood pressure status fell within the Hardy-Weinberg equilibrium. In postmenopausal women the FTO (rs178 17449) genotype was significantly associated with systolic blood pressure (SBP) (p = 0.024) in the dominant GG/GT vs.TT model and with diastolic blood pressure (DBP) (p = 0.030) in the recessive GG vs. GT/TT and the additive model (p = 0.043), respectively. In these postmenopausal women regression analysis showed a statistically significant effect of age, BMI and FTO dominant model on SBP, and of BMI on DBP among the other variables capable of inducing blood pressure differences. This study demonstrates that the SNP rs178 17449 in the FTO gene is associated with systolic and diastolic blood pressure but not with BMI and obesity variables, as already replicated in several populations throughout the world.
Menopause is associated with various physiological symptoms which can be related to the most common health problems in menopausal women and a decrease in their quality of life. Determinants of experiencing menopausal symptoms are complex because they include reproductive, environmental, lifestyle and social factors. The aim of this study is to assess whether selected reproductive, lifestyle and health factors are associated with the occurence of hot flushes, night sweats, palpitations, dizzy spells and/or pins and needles in the hands and feet. A total of 346 women aged between 39 and 59 years living in Slovakia were recruited for this cross-sectional survey. Data on menopausal symptoms and potential confounders were collected by questionnaire. Logistic regression analysis revealed an independent effect of peri-/postmenopausal status and depressed mood on the manifestation of hot flushes. Analysis results for night sweats were significant for age, depressed mood and current smoking at p<0.05 while, of all input parameters, only age and depressed mood were significant predictors of palpitations. Logistic regression also revealed the effect of sport and depressed mood on dizzy spells. Depressed women, (B=0.677) and those who did not participate in sporting activities (B= -0.969) suffered more often from dizzy spells. Pins and needles in hands and feet were influenced by peri-/postmenopausal status (B=1.036), by higher numbers of pregnancy (B=0.260) and depressed mood (B=0.505). Potentially modifiable factors, such as current smoking, lack of sport, depressed mood and the number of pregnancies can predispose a woman to a higher prevalence of some of these physiological menopausal symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.